During the past decade, Central Hospital of Minhang District conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Hospital of Minhang District" #1 sponsor was "Ruijin Hospital" with 2 trials, followed by "Shanghai Minhang Central Hospital" with 2 trials sponsored, "Ark Biosciences Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Hospital of Minhang District" #1 collaborator was "First Affiliated Hospital of Kunming Medical University" with 2 trials as a collaborator, "Jiangxi Provincial People's Hopital" with 2 trials as a collaborator, "Ningbo No. 1 Hospital" with 2 trials as a collaborator, "Second Hospital of Jilin University" with 2 trials as a collaborator and "Shanghai Jiao Tong University School of Medicine" with 2 trials as a collaborator. Other collaborators include 143 different institutions and companies that were collaborators in the rest 151 trials.

According to Clinical.Site data, the most researched conditions in "Central Hospital of Minhang District" are "Abnormal Mucus Secretions" (1 trials), "Acute Respiratory Infection" (1 trials), "Adverse Drug Reaction" (1 trials), "Atrial Fibrillation" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "Central Hospital of Minhang District" in a lesser frequency.

Most popular intervention types in "Central Hospital of Minhang District" are "Drug" (10 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "placebo" (2 trials), "AK0529" (1 trials), "Ambroxol hydrochloride 30 mg" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Hospital of Minhang District" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Central Hospital of Minhang District". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Central Hospital of Minhang District, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Hospital of Minhang District, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".